Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Gross Profit: 2009-2025

Historic Gross Profit for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $40.3 million.

  • Lifecore Biomedical's Gross Profit fell 19.05% to $14.0 million in Q2 2025 from the same period last year, while for May 2025 it was $40.3 million, marking a year-over-year decrease of 3.71%. This contributed to the annual value of $40.3 million for FY2025, which is 3.71% down from last year.
  • Lifecore Biomedical's Gross Profit amounted to $40.3 million in FY2025, which was down 3.71% from $41.9 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Gross Profit ranged from a high of $41.9 million in FY2024 and a low of $28.0 million during FY2023.
  • Its 3-year average for Gross Profit is $36.7 million, with a median of $40.3 million in 2025.
  • Per our database at Business Quant, Lifecore Biomedical's Gross Profit declined by 28.36% in 2023 and then surged by 49.54% in 2024.
  • Lifecore Biomedical's Gross Profit (Yearly) stood at $38.9 million in 2021, then increased by 0.33% to $39.1 million in 2022, then dropped by 28.36% to $28.0 million in 2023, then spiked by 49.54% to $41.9 million in 2024, then declined by 3.71% to $40.3 million in 2025.